![]() |
Exploring the past, present, and future of postoperative radiotherapy for N2 stage non-small cell lung cancer
Byoung Hyuck Kim, Jae Sik Kim, Hak Jae Kim
Radiat Oncol J. 2023;41(3):144-153. Published online 2023 Aug 23 DOI: https://doi.org/10.3857/roj.2023.00430
|
Citations to this article as recorded by
Advances in adjuvant therapy for operable N2 non-small cell lung cancer: a narrative review
Lei Liu, Yilong Mao, Leilei Guo, Chencong Li, Yiqian Wang
Frontiers in Oncology.2025;[Epub] CrossRef Risk of clinically significant cardiovascular disease associated with postoperative radiotherapy in non-small cell lung cancer patients receiving surgical resection followed by adjuvant chemotherapy: A Korean nationwide cohort study
Jeanny Kwon, Byoung Hyuck Kim
Radiotherapy and Oncology.2024; 195: 110241. CrossRef Mapping the patient journey and treatment patterns in early-stage (stage I-III) non-small cell lung cancer
Sarah Sharman Moser, Shira Yaari, Lior Apter, Bernadette Poellinger, Milan Rheenen, Ashwini Arunachalam, Gabriel Chodick, Moshe Hoshen, Sivan Gazit, Nava Siegelmann-Danieli
Cancer Epidemiology.2024; 93: 102678. CrossRef Artificial intelligence-assisted delineation for postoperative radiotherapy in patients with lung cancer: a prospective, multi-center, cohort study
Ziming Han, Yu Wang, Wenqing Wang, Tao Zhang, Jianyang Wang, Xiangyu Ma, Kuo Men, Anhui Shi, Yuyan Gao, Nan Bi
Frontiers in Oncology.2024;[Epub] CrossRef Recomendaciones para el diagnóstico, seguimiento y tratamiento cáncer del pulmón de células no pequeñas temprano en Colombia
Diego Hernando Pardo, Lucia Viola, Jairo Zuluaga, Leonardo Rojas, Iván Andrés Bobadilla, Stella Martínez, Iván José Bustillo, Luis Gerardo Garcia-Herreros, Ricardo Adolfo Zapata, Adriana Serna, Ana Margarita Baldión, Darwin José Padilla, Willfredy Castaño
Medicina.2023; 45(4): 767. CrossRef
|